Literature DB >> 6580292

Crystallization and preliminary x-ray studies of spinach ribulose 1,5-bisphosphate carboxylase/oxygenase complexed with activator and a transition state analogue.

I Andersson, A C Tjäder, E Cedergren-Zeppezauer, C I Brändén.   

Abstract

Ribulose 1,5-bisphosphate carboxylase/oxygenase has been purified from spinach and crystallized by equilibrium vapor diffusion with polyethylene glycol 6000 as a precipitant. Crystals suitable for x-ray studies were obtained from a binary complex with a transition state analogue, 2-C-carboxy-D-arabinitol 1,5-bisphosphate, and a quaternary complex with 2-C-carboxy-D-arabinitol 1,5-bisphosphate, Mg2+, and HCO-3. Two forms of crystals were obtained in the presence of 2-C-carboxy-D-arabinitol 1,5-bisphosphate. Form B crystals are plates which have orthorhombic space group P2(1)2(1)2 with unit cell dimensions a = 184 A, b = 218 A, and c = 119 A. Form C crystals are tetragonal needles with space group I422 and with cell dimensions a = b = 275 A and c = 178 A. In both forms, the asymmetric unit contains half a molecule.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6580292

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  1 in total

1.  Electrospray sample injection for single-particle imaging with x-ray lasers.

Authors:  Johan Bielecki; Max F Hantke; Benedikt J Daurer; Hemanth K N Reddy; Dirk Hasse; Daniel S D Larsson; Laura H Gunn; Martin Svenda; Anna Munke; Jonas A Sellberg; Leonie Flueckiger; Alberto Pietrini; Carl Nettelblad; Ida Lundholm; Gunilla Carlsson; Kenta Okamoto; Nicusor Timneanu; Daniel Westphal; Olena Kulyk; Akifumi Higashiura; Gijs van der Schot; Ne-Te Duane Loh; Taylor E Wysong; Christoph Bostedt; Tais Gorkhover; Bianca Iwan; M Marvin Seibert; Timur Osipov; Peter Walter; Philip Hart; Maximilian Bucher; Anatoli Ulmer; Dipanwita Ray; Gabriella Carini; Ken R Ferguson; Inger Andersson; Jakob Andreasson; Janos Hajdu; Filipe R N C Maia
Journal:  Sci Adv       Date:  2019-05-03       Impact factor: 14.136

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.